Antibiotic GE37468A: a new inhibitor of bacterial protein synthesis. III. Strain and fermentation study

J Antibiot (Tokyo). 1996 Sep;49(9):880-5. doi: 10.7164/antibiotics.49.880.

Abstract

GE37468A is a new thiazolyl peptide antibiotic acting on Elongation Factor Tu, produced by fermentation of Streptomyces sp. ATCC 55365. The low (< 10 mg/liter) and poorly reproducible antibiotic productivity of the original soil isolate hampered the development of a scalable fermentation process. A tenfold increase of GE37468A productivity was achieved by selection of spontaneous morphochromatic variants, which appeared at high frequency in the wild type population. The higher producing ATCC 55365/O/5 colony was tyrosinase defective and blocked in the aerial mycelium differentiation (Amy-Mel- phenotype). The fermentation process of this stable and purified strain was rapidly optimized to achieve a further fourfold improvement in a fed-batch process.

MeSH terms

  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / pharmacology
  • Fermentation / physiology*
  • Peptides, Cyclic / metabolism*
  • Peptides, Cyclic / pharmacology
  • Phenotype
  • Protein Synthesis Inhibitors / metabolism
  • Protein Synthesis Inhibitors / pharmacology
  • Soil Microbiology
  • Streptomyces / metabolism*
  • Thiazoles / metabolism*
  • Thiazoles / pharmacology

Substances

  • Anti-Bacterial Agents
  • GE 37468 A
  • Peptides, Cyclic
  • Protein Synthesis Inhibitors
  • Thiazoles